Table of Contents 1 Market Overview 1.1 CINV Existing and Pipeline Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global CINV Existing and Pipeline Drugs Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Aloxi (palonosetron) 1.2.3 Zofran Generic (ondansetron) 1.2.4 Kytril Generic (granisetron) 1.2.5 Emend (aprepitant) 1.2.6 Akynzeo (netupitant-palonosetron) 1.2.7 SUSTOL (extended release granisetron injection) 1.2.8 Rolapitant 1.3 Market Analysis by Application 1.3.1 Overview: Global CINV Existing and Pipeline Drugs Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Hospitals 1.3.3 Specialty Clinics 1.3.4 Diagnostic Centers Therapeutics 1.3.5 Hospital Pharmacies 1.3.6 Drugstores 1.4 Overview of Global CINV Existing and Pipeline Drugs Market 1.4.1 Global CINV Existing and Pipeline Drugs Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 GlaxoSmithKline 2.1.1 GlaxoSmithKline Details 2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 GlaxoSmithKline SWOT Analysis 2.1.4 GlaxoSmithKline Product and Services 2.1.5 GlaxoSmithKline CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 Merck 2.2.1 Merck Details 2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 Merck SWOT Analysis 2.2.4 Merck Product and Services 2.2.5 Merck CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Helsinn 2.3.1 Helsinn Details 2.3.2 Helsinn Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Helsinn SWOT Analysis 2.3.4 Helsinn Product and Services 2.3.5 Helsinn CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Heron Therapeutics 2.4.1 Heron Therapeutics Details 2.4.2 Heron Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Heron Therapeutics SWOT Analysis 2.4.4 Heron Therapeutics Product and Services 2.4.5 Heron Therapeutics CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Tesaro 2.5.1 Tesaro Details 2.5.2 Tesaro Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Tesaro SWOT Analysis 2.5.4 Tesaro Product and Services 2.5.5 Tesaro CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global CINV Existing and Pipeline Drugs Sales and Market Share by Manufacturer (2018-2019) 3.2 Global CINV Existing and Pipeline Drugs Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 CINV Existing and Pipeline Drugs Manufacturer Market Share in 2019 3.3.2 Top 6 CINV Existing and Pipeline Drugs Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global CINV Existing and Pipeline Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global CINV Existing and Pipeline Drugs Sales and Market Share by Regions (2015-2020) 4.1.2 Global CINV Existing and Pipeline Drugs Revenue and Market Share by Regions (2015-2020) 4.2 North America CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 4.3 Europe CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 4.5 South America CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America CINV Existing and Pipeline Drugs Sales, Revenue and Market Share by Country 5.1.1 North America CINV Existing and Pipeline Drugs Sales and Market Share by Country (2015-2020) 5.1.2 North America CINV Existing and Pipeline Drugs Revenue and Market Share by Country (2015-2020) 5.2 United States CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 5.3 Canada CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 5.4 Mexico CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe CINV Existing and Pipeline Drugs Sales, Revenue and Market Share by Country 6.1.1 Europe CINV Existing and Pipeline Drugs Sales and Market Share by Country (2015-2020) 6.1.2 Europe CINV Existing and Pipeline Drugs Revenue and Market Share by Country (2015-2020) 6.2 Germany CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 6.3 UK CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 6.4 France CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 6.5 Russia CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 6.6 Italy CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific CINV Existing and Pipeline Drugs Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific CINV Existing and Pipeline Drugs Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific CINV Existing and Pipeline Drugs Revenue and Market Share by Regions (2015-2020) 7.2 China CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 7.3 Japan CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 7.4 Korea CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 7.5 India CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 7.6 Southeast Asia CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 7.7 Australia CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America CINV Existing and Pipeline Drugs Sales, Revenue and Market Share by Country 8.1.1 South America CINV Existing and Pipeline Drugs Sales and Market Share by Country (2015-2020) 8.1.2 South America CINV Existing and Pipeline Drugs Revenue and Market Share by Country (2015-2020) 8.2 Brazil CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 8.3 Argentina CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa CINV Existing and Pipeline Drugs Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa CINV Existing and Pipeline Drugs Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa CINV Existing and Pipeline Drugs Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 9.3 Turkey CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 9.4 Egypt CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 9.5 South Africa CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global CINV Existing and Pipeline Drugs Sales and Market Share by Type (2015-2020) 10.2 Global CINV Existing and Pipeline Drugs Revenue and Market Share by Type (2015-2020) 10.3 Global CINV Existing and Pipeline Drugs Price by Type (2015-2020) 11 Global CINV Existing and Pipeline Drugs Market Segment by Application 11.1 Global CINV Existing and Pipeline Drugs Sales Market Share by Application (2015-2020) 11.2 Global CINV Existing and Pipeline Drugs Revenue Market Share by Application (2015-2020) 11.3 Global CINV Existing and Pipeline Drugs Price by Application (2015-2020) 12 Market Forecast 12.1 Global CINV Existing and Pipeline Drugs Sales, Revenue and Growth Rate (2021-2025) 12.2 CINV Existing and Pipeline Drugs Market Forecast by Regions (2021-2025) 12.2.1 North America CINV Existing and Pipeline Drugs Market Forecast (2021-2025) 12.2.2 Europe CINV Existing and Pipeline Drugs Market Forecast (2021-2025) 12.2.3 Asia-Pacific CINV Existing and Pipeline Drugs Market Forecast (2021-2025) 12.2.4 South America CINV Existing and Pipeline Drugs Market Forecast (2021-2025) 12.2.5 Middle East & Africa CINV Existing and Pipeline Drugs Market Forecast (2021-2025) 12.3 CINV Existing and Pipeline Drugs Market Forecast by Type (2021-2025) 12.3.1 Global CINV Existing and Pipeline Drugs Sales Forecast by Type (2021-2025) 12.3.2 Global CINV Existing and Pipeline Drugs Market Share Forecast by Type (2021-2025) 12.4 CINV Existing and Pipeline Drugs Market Forecast by Application (2021-2025) 12.4.1 Global CINV Existing and Pipeline Drugs Sales Forecast by Application (2021-2025) 12.4.2 Global CINV Existing and Pipeline Drugs Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global CINV Existing and Pipeline Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of CINV Existing and Pipeline Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global CINV Existing and Pipeline Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table 8. GlaxoSmithKline CINV Existing and Pipeline Drugs Major Business Table 9. GlaxoSmithKline CINV Existing and Pipeline Drugs Total Revenue (USD Million) (2018-2019) Table 10. GlaxoSmithKline SWOT Analysis Table 11. GlaxoSmithKline CINV Existing and Pipeline Drugs Product and Services Table 12. GlaxoSmithKline CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. Merck Basic Information, Manufacturing Base and Competitors Table 14. Merck CINV Existing and Pipeline Drugs Major Business Table 15. Merck CINV Existing and Pipeline Drugs Total Revenue (USD Million) (2018-2019) Table 16. Merck SWOT Analysis Table 17. Merck CINV Existing and Pipeline Drugs Product and Services Table 18. Merck CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Helsinn Basic Information, Manufacturing Base and Competitors Table 20. Helsinn CINV Existing and Pipeline Drugs Major Business Table 21. Helsinn CINV Existing and Pipeline Drugs Total Revenue (USD Million) (2018-2019) Table 22. Helsinn SWOT Analysis Table 23. Helsinn CINV Existing and Pipeline Drugs Product and Services Table 24. Helsinn CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Heron Therapeutics Basic Information, Manufacturing Base and Competitors Table 26. Heron Therapeutics CINV Existing and Pipeline Drugs Major Business Table 27. Heron Therapeutics CINV Existing and Pipeline Drugs Total Revenue (USD Million) (2018-2019) Table 28. Heron Therapeutics SWOT Analysis Table 29. Heron Therapeutics CINV Existing and Pipeline Drugs Product and Services Table 30. Heron Therapeutics CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. Tesaro Basic Information, Manufacturing Base and Competitors Table 32. Tesaro CINV Existing and Pipeline Drugs Major Business Table 33. Tesaro CINV Existing and Pipeline Drugs Total Revenue (USD Million) (2018-2019) Table 34. Tesaro SWOT Analysis Table 35. Tesaro CINV Existing and Pipeline Drugs Product and Services Table 36. Tesaro CINV Existing and Pipeline Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. Global CINV Existing and Pipeline Drugs Sales by Manufacturer (2018-2019) (Kg) Table 38. Global CINV Existing and Pipeline Drugs Revenue by Manufacturer (2018-2019) (USD Million) Table 39. Global CINV Existing and Pipeline Drugs Sales by Regions (2015-2020) (Kg) Table 40. Global CINV Existing and Pipeline Drugs Sales Market Share by Regions (2015-2020) Table 41. Global CINV Existing and Pipeline Drugs Revenue by Regions (2015-2020) (USD Million) Table 42. North America CINV Existing and Pipeline Drugs Sales by Countries (2015-2020) (Kg) Table 43. North America CINV Existing and Pipeline Drugs Sales Market Share by Countries (2015-2020) Table 44. North America CINV Existing and Pipeline Drugs Revenue by Countries (2015-2020) (USD Million) Table 45. North America CINV Existing and Pipeline Drugs Revenue Market Share by Countries (2015-2020) Table 46. Europe CINV Existing and Pipeline Drugs Sales by Countries (2015-2020) (Kg) Table 47. Europe CINV Existing and Pipeline Drugs Sales Market Share by Countries (2015-2020) Table 48. Europe CINV Existing and Pipeline Drugs Revenue by Countries (2015-2020) (USD Million) Table 49. Asia-Pacific CINV Existing and Pipeline Drugs Sales by Regions (2015-2020) (Kg) Table 50. Asia-Pacific CINV Existing and Pipeline Drugs Sales Market Share by Regions (2015-2020) Table 51. Asia-Pacific CINV Existing and Pipeline Drugs Revenue by Regions (2015-2020) (USD Million) Table 52. South America CINV Existing and Pipeline Drugs Sales by Countries (2015-2020) (Kg) Table 53. South America CINV Existing and Pipeline Drugs Sales Market Share by Countries (2015-2020) Table 54. South America CINV Existing and Pipeline Drugs Revenue by Countries (2015-2020) (USD Million) Table 55. South America CINV Existing and Pipeline Drugs Revenue Market Share by Countries (2015-2020) Table 56. Middle East & Africa CINV Existing and Pipeline Drugs Sales by Countries (2015-2020) (Kg) Table 57. Middle East & Africa CINV Existing and Pipeline Drugs Sales Market Share by Countries (2015-2020) Table 58. Middle East & Africa CINV Existing and Pipeline Drugs Revenue by Countries (2015-2020) (USD Million) Table 59. Middle East & Africa CINV Existing and Pipeline Drugs Revenue Market Share by Countries (2015-2020) Table 60. Global CINV Existing and Pipeline Drugs Sales by Type (2015-2020) (Kg) Table 61. Global CINV Existing and Pipeline Drugs Sales Share by Type (2015-2020) Table 62. Global CINV Existing and Pipeline Drugs Revenue by Type (2015-2020) (USD Million) Table 63. Global CINV Existing and Pipeline Drugs Revenue Share by Type (2015-2020) Table 64. Global CINV Existing and Pipeline Drugs Sales by Application (2015-2020) (Kg) Table 65. Global CINV Existing and Pipeline Drugs Sales Share by Application (2015-2020) Table 66. Global CINV Existing and Pipeline Drugs Sales Forecast by Regions (2021-2025) (Kg) Table 67. Global CINV Existing and Pipeline Drugs Market Share Forecast by Regions (2021-2025) Table 68. Global CINV Existing and Pipeline Drugs Sales Forecast by Type (2021-2025) (Kg) Table 69. Global CINV Existing and Pipeline Drugs Market Share Forecast by Type (2021-2025) Table 70. Global CINV Existing and Pipeline Drugs Sales Forecast by Application (2021-2025) Table 71. Global CINV Existing and Pipeline Drugs Market Share Forecast by Application (2021-2025) Table 72. Direct Channel Pros & Cons Table 73. Indirect Channel Pros & Cons Table 74. Distributors/Traders/ Dealers List List of Figures Figure 1. CINV Existing and Pipeline Drugs Picture Figure 2. Global Sales Market Share of CINV Existing and Pipeline Drugs by Type in 2019 Figure 3. Aloxi (palonosetron) Picture Figure 4. Zofran Generic (ondansetron) Picture Figure 5. Kytril Generic (granisetron) Picture Figure 6. Emend (aprepitant) Picture Figure 7. Akynzeo (netupitant-palonosetron) Picture Figure 8. SUSTOL (extended release granisetron injection) Picture Figure 9. Rolapitant Picture Figure 10. CINV Existing and Pipeline Drugs Sales Market Share by Application in 2018 Figure 11. Hospitals Picture Figure 12. Specialty Clinics Picture Figure 13. Diagnostic Centers Therapeutics Picture Figure 14. Hospital Pharmacies Picture Figure 15. Drugstores Picture Figure 16. Global CINV Existing and Pipeline Drugs Market Status and Outlook (2015-2025) (USD Million) Figure 17. United States CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 18. Canada CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 19. Mexico CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 20. Germany CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 21. France CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 22. UK CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 23. Russia CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 24. Italy CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 25. China CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 26. Japan CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 27. Korea CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 28. India CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 29. Southeast Asia CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 30. Australia CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 31. Brazil CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 32. Egypt CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 33. Saudi Arabia CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 34. South Africa CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 35. Turkey CINV Existing and Pipeline Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 36. Global CINV Existing and Pipeline Drugs Sales Market Share by Manufacturer in 2019 Figure 37. Global CINV Existing and Pipeline Drugs Revenue Market Share by Manufacturer in 2019 Figure 38. Top 3 CINV Existing and Pipeline Drugs Manufacturer (Revenue) Market Share in 2019 Figure 39. Top 6 CINV Existing and Pipeline Drugs Manufacturer (Revenue) Market Share in 2019 Figure 40. Key Manufacturer Market Share Trend Figure 41. Global CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 42. Global CINV Existing and Pipeline Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 43. Global CINV Existing and Pipeline Drugs Revenue Market Share by Regions (2015-2020) Figure 44. Global CINV Existing and Pipeline Drugs Revenue Market Share by Regions in 2018 Figure 45. North America CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) Figure 46. Europe CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) Figure 47. Asia-Pacific CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) Figure 48. South America CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) Figure 49. Middle East & Africa CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) Figure 50. North America CINV Existing and Pipeline Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 51. North America CINV Existing and Pipeline Drugs Sales Market Share by Countries (2015-2020) Figure 52. North America CINV Existing and Pipeline Drugs Sales Market Share by Countries in 2018 Figure 53. North America CINV Existing and Pipeline Drugs Revenue Market Share by Countries (2015-2020) (USD Million) Figure 54. North America CINV Existing and Pipeline Drugs Revenue Market Share by Countries in 2018 Figure 55. United States CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 56. Canada CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 57. Mexico CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 58. Europe CINV Existing and Pipeline Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 59. Europe CINV Existing and Pipeline Drugs Revenue Market Share by Countries (2015-2020) Figure 60. Europe CINV Existing and Pipeline Drugs Revenue Market Share by Countries in 2019 Figure 61. Germany CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 62. UK CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 63. France CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 64. Russia CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 65. Italy CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 66. Asia-Pacific CINV Existing and Pipeline Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 67. Asia-Pacific CINV Existing and Pipeline Drugs Sales Market Share by Regions 2019 Figure 68. Asia-Pacific CINV Existing and Pipeline Drugs Revenue Market Share by Regions 2019 Figure 69. China CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 70. Japan CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 71. Korea CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 72. India CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 73. Southeast Asia CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 74. South America CINV Existing and Pipeline Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 75. South America CINV Existing and Pipeline Drugs Sales Market Share by Countries in 2019 Figure 76. South America CINV Existing and Pipeline Drugs Revenue Market Share by Countries in 2019 Figure 77. Brazil CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 78. Argentina CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 79. Middle East and Africa CINV Existing and Pipeline Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 80. Middle East and Africa CINV Existing and Pipeline Drugs Sales Market Share by Countries in 2019 Figure 81. Middle East and Africa CINV Existing and Pipeline Drugs Revenue Market Share by Countries (2015-2020) Figure 82. Middle East and Africa CINV Existing and Pipeline Drugs Revenue Market Share by Countries in 2019 Figure 83. Saudi Arabia CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 84. Egypt CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 85. Turkey CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 86. South Africa CINV Existing and Pipeline Drugs Sales and Growth Rate (2015-2020) (Kg) Figure 87. Global CINV Existing and Pipeline Drugs Sales and Growth Rate (2021-2025) (Kg) Figure 88. Global CINV Existing and Pipeline Drugs Revenue and Growth Rate (2021-2025) (USD Million) Figure 89. North America Sales CINV Existing and Pipeline Drugs Market Forecast (2021-2025) (Kg) Figure 90. Europe Sales CINV Existing and Pipeline Drugs Market Forecast (2021-2025) (Kg) Figure 91. Asia-Pacific Sales CINV Existing and Pipeline Drugs Market Forecast (2021-2025) (Kg) Figure 92. South America Sales CINV Existing and Pipeline Drugs Market Forecast (2021-2025) (Kg) Figure 93. Middle East & Africa Sales CINV Existing and Pipeline Drugs Market Forecast (2021-2025) (Kg) Figure 94. Sales Channel: Direct Channel vs Indirect Channel

GlaxoSmithKline Merck Helsinn Heron Therapeutics Tesaro